Literature DB >> 27318479

The need for supportive care among head and neck cancer patients: psychometric assessment of the Dutch version of the Supportive Care Needs Survey Short-Form (SCNS-SF34) and the newly developed head and neck cancer module (SCNS-HNC).

Femke Jansen1, Birgit I Witte2, Cornelia F van Uden-Kraan3, Anna M Braspenning3, C René Leemans1, Irma M Verdonck-de Leeuw4,5.   

Abstract

PURPOSE: The purpose of this study is to assess the psychometric properties of the Dutch version of the 34-item Short-Form Supportive Care Needs Survey (SCNS-SF34) and the newly developed module for head and neck cancer (HNC) patients (SCNS-HNC).
METHODS: HNC patients were included from two cross-sectional studies. Content validity of the SCNS-HNC was analysed by examining redundancy and completeness of items. Factor structure was assessed using confirmatory and exploratory factor analyses. Cronbach's alpha, Spearman's correlation, Mann-Whitney U test, Kruskall-Wallis and intraclass correlation coefficients (ICC) were used to assess internal consistency, construct validity and test-retest reliability.
RESULTS: Content validity of the SCNS-HNC was good, although some HNC topics were missing. For the SCNS-SF34, a four-factor structure was found, namely physical and daily living, psychological, sexuality and health system and information and patient support (alpha = .79 to .95). For the SCNS-HNC, a two-factor structure was found, namely HNC-specific functioning and lifestyle (alpha = .89 and .60). Respectively, 96 and 89 % of the hypothesised correlations between the SCNS-SF34 or SCNS-HNC and other patient-reported outcome measures were found; 57 and 67 % also showed the hypothesised magnitude of correlation. The SCNS-SF34 domains discriminated between treatment procedure (physical and daily living p = .02 and psychological p = .01) and time since treatment (health system, information and patient support p = .02). Test-retest reliability of SCNS-SF34 domains and HNC-specific functioning domain was above .70 (ICC = .74 to .83), and ICC = .67 for the lifestyle domain. Floor effects ranged from 21.1 to 70.9 %.
CONCLUSIONS: The SCNS-SF34 and SCNS-HNC are valid and reliable instruments to evaluate the need for supportive care among (Dutch) HNC patients.

Entities:  

Keywords:  Head and neck cancer; Internal consistency; Psychometric characteristics; Reliability; Supportive care needs; Validity

Mesh:

Year:  2016        PMID: 27318479      PMCID: PMC5031728          DOI: 10.1007/s00520-016-3307-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


Introduction

Head and neck cancer (HNC) patients often experience generic cancer-related problems, such as pain, fatigue [1], anxiety [2] and depression [3] as well as HNC-specific problems such as dysphagia [4], or problems with speech [5], nutrition [6] and hearing [7], influencing their quality of life [1, 6]. Supportive care (SC), defined as the prevention and management of adverse effects of cancer and its treatment [8], can help improve these problems. In order to provide adequate SC tailored to patients’ wishes and needs, insight into their perceived need for SC is required. A frequently used patient-reported outcome measure (PROM) on generic cancer-related SC needs is the 34-item Short-Form Supportive Care Needs Survey (SCNS-SF34). The SCNS-SF34 measures the need and level of need for SC, including physical and daily living, psychological, sexuality, patient care and support and health system and information needs [9, 10]. Currently, the SCNS-SF34 has been translated and validated in English [9, 11], French [12], German [13], Italian [14], Mexican [15], Chinese [16, 17] and Japanese [18] populations, including breast [12, 16, 18], colorectal [17], prostate [11] and mixed [9, 13–15] cancer patients. A Dutch translation of the SCNS-SF34 has not been validated so far. In addition, the SCNS-SF34 has not yet been validated among HNC patients. Cross validation of PROMs, when translated into a different language or used in a different cancer population, is of importance, since lingual, cultural and population differences may affect psychometric characteristics. Supplementary modules for use in conjunction with the SCNS-SF34 have been developed to measure SC needs specific for breast [19, 20], melanoma [21] and prostate [22] cancer patients. Henry et al. [23] added four items (alcohol cessation, smoking cessation, feeling better about my appearance and finding meaning and purpose in life) to the SCNS-SF34, which were expected to be relevant to HNC patients; however, these items were not validated. Therefore, we developed an HNC-specific module (SCNS-HNC) by multidisciplinary team discussions consisting of a physician, speech pathologist, linguist, psychologist and health scientist, which we previously used to identify cutoff scores on the European Organisation for Research and Treatment of Cancer (EORTC) head and neck cancer-specific quality of life questionnaire (EORTC QLQ-H&N35) [24]. The aim of this study was to assess the psychometric properties (i.e. internal consistency, validity and test–retest reliability) of the Dutch version of the SCNS-SF34 and SCNS-HNC in HNC patients.

Patients and methods

Design and study participants

Patients were included from two cross-sectional studies conducted at the Department of Otolaryngology—Head and Neck Surgery of the VU University Medical Center (VUmc), Amsterdam, The Netherlands. The first study included HNC patients who visited the department from April to September 2013 and who participated in an evaluation study of a touch screen computer-assisted PROM system, which is part of standard clinical practice (called OncoQuest) [25]. After completing OncoQuest, all eligible patients were asked to fill in a questionnaire at home using paper and pencil (including the SCNS-SF34 and SCNS-HNC). In addition, all patients who discussed the results of OncoQuest with an oncology nurse (also part of standard clinical practice) were asked whether they agreed to have a researcher present during this nursing consultation. The researcher completed a study-specific report form regarding this consultation. The second study included HNC patients who visited the department in February or March 2015. All eligible patients were asked to fill in a questionnaire at home using paper and pencil (including the SCNS-SF34 and SCNS-HNC). In addition, all patients who completed the first questionnaire in this second study were asked to complete the SCNS-SF34 and SCNS-HNC a second time 1–2 weeks later (for test–retest analyses). Completed questionnaires were sent back to VUmc. In case of missing data, clarifications were sought over the telephone. Patients were included in this particular study when they (1) were treated with curative intent for cancer of the oral cavity, pharynx, larynx, nasal cavity or major salivary glands; (2) were between 3 months and 5 years after last treatment; and (3) were ≥18 years old. Patients were excluded when they had cognitive impairments or did not understand the Dutch language. According to the Dutch Medical Research Involving Human Subjects Act, ethical approval was not necessary, because patients were not subjected to procedures or required to follow rules of behaviour.

Measures

SCNS-SF34

The SCNS-SF34 measures the need and level of need for SC in the last month on 34 items on a five-point, two-level response scale [9, 10]. The first response scale consists of two broad categories of need, i.e. ‘no need’ and ‘need’. The ‘no need’ scale is further subdivided into ‘not applicable’ for issues that were no problem to the patient, and ‘satisfied’ for issues on which a patient needed support but the support was satisfactory. The ‘need’ category has three subcategories indicating the level of need for additional care, namely ‘low need’, ‘moderate need’ and ‘high need’. According to the original study of Boyes et al. [9] among mixed cancer patients, SC needs can be subdivided into the following five underlying domains: physical and daily living, psychological, sexuality, patient care and support and health system and information. An alternative factor structure was suggested by Au et al. [16] among breast cancer patients, who found four underlying domains using 33 items: physical and daily living, psychological, sexuality and health system, information and patient support. A total score per domain can be calculated and converted to a standardized 0–100 score, with a higher score indicating a higher level of need [10]. The SCNS-SF34 was translated into Dutch according to the EORTC guideline [26]. A translator and a nurse specialist (both Dutch native speakers) translated the SCNS-SF34 into Dutch. The translations were compared by two of the authors (FJ and IV), and slight discrepancies were solved by discussion in order to provide one Dutch version. By means of back translation, the Dutch version was converted into English by two independently working native English-speaking persons and compared by the two authors to the original English version.

SCNS-HNC

The SCNS-HNC measures the need for SC concerning 11 HNC-specific issues using the same response scale as the SCNS-SF34. In addition, a single free-text item was added, where patients could report any additional needs, which were not yet taken into account in the SCNS-SF34 or SCNS-HNC. This free-text item was added to analyse whether supportive care needs were missing from the patient perspective. Reading age of the SCNS-HNC calculated using the formula of Douma (formula of Flesch–Kincaid Grade adjusted for Dutch situation) was 13–15 years [27].

Other PROMs and clinical measures

All HNC patients also completed the EORTC generic (EORTC QLQ-C30) [28] and HNC-specific (EORTC QLQ-H&N35) [29] quality of life measure, the Hospital Anxiety and Depression Scale (HADS) [30], the speech handicap index (SHI) [31] and a PROM evaluating swallowing problems (SWAL-QOL) [32]. In the first study, these PROMs were completed using OncoQuest [25], while in the second, study they were assessed concurrently with the SCNS-SF34 and SCNS-HNC. Besides, in the first study, a study-specific report form was completed by an observing researcher, who was present during the nursing consultation following OncoQuest. This report form included information on topics, information and SC options discussed during the nursing consultation. Finally, socio-demographic characteristics were patient-reported, and clinical characteristics were retrieved from patients’ medical records.

Data analyses

Content validity of the SCNS-HNC was analysed by examining redundancy and completeness of items. Items were considered redundant if <10 % of the patients reported a need (or in case of SCNS-HNC item 6, <10% of patients were treated with total laryngectomy). Completeness of the SCNS-HNC was examined by analysing SC needs reported on the free-text item of the SCNS-HNC and analysing needs discussed during the nursing consultation as assessed in the study-specific report form. If ≥5 % of patients reported or discussed an additional SC need, adding this specific need to the SCNS-HNC should be considered. Confirmatory factor analysis was used to analyse whether the original five-factor [9] or alternative four-factor structure [16] of the SCNS-SF34 could be replicated, as proposed by Terwee et al. [33]. Criteria for an acceptable fit were root mean square error of approximation (RMSEA) <.06, comparative fit index (CFI) and Tucker–Lewis index—non-normed fit index ≥.9. Principal component analysis with varimax rotation of factors with eigenvalues >1.0 was used to analyse the factor structure of the SCNS-HNC. Appropriateness of principal component analysis was examined using Bartlett’s test of sphericity (p < .05) and the Kaiser, Meyer Olkin index of sampling adequacy (KMO ≥ .60). Internal consistency was assessed using Cronbach’s alpha coefficient, that is, a value between .70 and .95 is considered good [33]. To analyse construct validity, a priori hypotheses were formulated regarding the correlation between the SCNS-SF34 (31 hypotheses) or SCNS-HNC (9 hypotheses) and other PROMs (EORTC QLQ-C30, EORTC QLQ-H&N35, HADS, SHI and SWAL-QOL; presented in Table 1) and expected differences between groups of HNC patients (13 hypotheses). Hypotheses were based on previous studies [9, 11–13, 16, 18, 34–36] and researchers’ expectations. Regarding expected differences, it was expected that (1) younger patients (18–60 years) reported a higher level of need than older patients (>60 years) on all domains except for physical and daily living [12, 13, 16, 18, 35]; (2) females reported a higher level of need on the physical and daily living and psychological domain [13], while males reported a higher level of need on the sexuality domain [13, 35]; (3) patients with multimodality treatment reported a higher level of need on all domains but sexuality than patients who received single treatment; and (4) patients long after treatment reported a lower need on the patient care and support and health system and information domains [36]. Correlations were analysed using Spearman’s correlation coefficient, since needs were non-normal distributed. Magnitude of the correlations were defined as moderate (r = 0.30 to 0.50) or strong (r > 0.50) [37]. Differences between groups of HNC patients were analysed using Mann–Whitney U test or Kruskall–Wallis. A p value of <.05 was considered statistically significant. The SCNS-SF34 and/or SCNS-HNC were found to be valid if at least 75 % of the hypotheses were in correspondence with the a priori defined hypotheses [33].
Table 1

A priori defined hypotheses regarding the (magnitude of the) correlation of domains of the SCNS-SF34 and items of the SCNS-HNC with other patient-reported outcome measures and the found correlation

SCNS-SF34SCNS-HNC
P&DLPSYSEXPC&S HIS&PSe HS&Ie Chewing or swallowingDry mouth and/or sticky mucusProblems with weightTo be informed on nutritionDifficulty speaking
HADS
 Anxiety .48 a .65 b .34 a .51a a
 Depression.61a .64 b .33 a .57a a
EORTC-QLQ-C30
 Physical functioning−.50d
 Role functioning−.63c
 Emotional functioning−.56c −.64 d −.47 c c
 Cognitive functioning −.43 c −.47 c
 Social functioning−.54c
 Global quality of life −.55 d −.51c
 Fatigue .64 b .55a .52a
 Pain.47b .42 a
 Dyspnoea.19a
 Sleep/insomnia .42 a
 Appetite loss .44 a .38 a
EORTC QLQ-HN35
 Swallowing .62 b
 Dry mouth.55a
 Sticky saliva.57a
 Weight loss .40 a
 Weight gain.08a
 Speech .61 b
 Sexuality .47 a
SWAL-QOL
 Symptom .62 b
 Food selection .48 a
SHI total score .64 b

If the a priori defined hypothesis was supported, the coefficient was italicized

P&DL physical and daily living, PSY psychological, SEX sexuality, PC&S patient care and support, HS&I health system and information

aA positive moderate (r = .30–.50) association was expected

bA positive strong (r > .50) association was expected

cA negative moderate (r = −.30 to −.50) association was expected

dA negative strong (r < −.50) association was expected

eSince a four-factor structure was found, we only present correlations of the combined HIS&PS domain

A priori defined hypotheses regarding the (magnitude of the) correlation of domains of the SCNS-SF34 and items of the SCNS-HNC with other patient-reported outcome measures and the found correlation If the a priori defined hypothesis was supported, the coefficient was italicized P&DL physical and daily living, PSY psychological, SEX sexuality, PC&S patient care and support, HS&I health system and information aA positive moderate (r = .30–.50) association was expected bA positive strong (r > .50) association was expected cA negative moderate (r = −.30 to −.50) association was expected dA negative strong (r < −.50) association was expected eSince a four-factor structure was found, we only present correlations of the combined HIS&PS domain Test–retest reliability was analysed using intraclass correlation coefficients (ICC) with absolute agreement in patients who completed the second questionnaire within 1 month after the first. An ICC value ≥.70 has been considered good [33]. Finally, floor or ceiling effects (>15 % of patients with the lowest or highest possible score) were investigated using frequency tables. All analyses were performed using the IBM Statistical Package for the Social Science (SPSS) version 22 (IBM Corp., Armonk, NY, USA) and Mplus version 6.11 (Muthen & Muthen, Los Angeles, CA, USA) [38].

Sample size calculation

For this study, at least 170 patients were needed for factor analyses (five times the number of SCNS-SF34 items), 50 patients per subgroup for construct validity analyses and 50 patients for test–retest reliability [33].

Results

Study sample

In total, 201 patients were included for content analyses, factor analyses and construct validity analyses; 110 patients for test–retest analyses; and 69 patients for content analysis using the study-specific report forms. Socio-demographic and clinical characteristics are presented in Table 2.
Table 2

Characteristics of the study samples

CharacteristicsFactor analyses and construct validity (n = 201)Test–retest reliability (n = 110)Content validity (study specific report form) (n = 69)
%%%
Age
 18–60 years31.325.546.4
 >60 years68.774.553.6
Sex
 Male66.772.763.8
 Female33.327.336.2
Living arrangements
 Living alone24.430.014.3a
 Living with partner58.759.159.2
 Living with partner and children15.410.022.4
 Other (e.g. with children)1.5.94.1
Education
 Elementary education6.53.65.8a
 Lower education37.840.024.6
 Secondary education26.925.523.2
 Higher education28.930.917.4
Employment status
 Employed (paid/unpaid)35.830.942.9a
 Unemployed12.511.816.3
 Housewife/houseman3.53.64.1
 Retired48.353.636.7
Tumour site
 Oral cavity31.333.630.4
 Pharynx36.835.536.2
 Larynx19.920.917.4
 Nasal cavity6.04.58.7
 Major salivary glands6.05.57.2
Disease stage (UICC)
 Stage I27.930.923.2
 Stage II13.410.021.7
 Stage III16.416.418.8
 Stage IV36.834.534.8
 Unknown5.58.21.4
Type of treatment
 Surgery25.425.527.5
 Radiotherapy20.421.823.2
 Surgery and chemoradiation8.57.35.8
 Surgery and radiation22.422.723.2
 Chemoradiation23.422.720.3
Time since last treatment
 <1 year38.834.544.9
 1–2 year29.931.826.1
 >2 year31.333.629.0

aLiving arrangement, education and employment status are missing in 20 patients

Characteristics of the study samples aLiving arrangement, education and employment status are missing in 20 patients

Content validity of the SCNS-HNC

On all SCNS-HNC items, ≥10 % of the patients reported a need, indicating that there were no redundant items. Regarding completeness, two of the 201 patients who filled in the SCNS-HNC reported on the free-text item that they had an additional need not yet taken into account in the questionnaire, one indicated to have needs regarding pain and one regarding psychological distress. The study-specific report form of the nursing consultation following OncoQuest revealed some frequently discussed HNC-specific issues not yet included in the SCNS-HNC, namely coughing and breathlessness (23 %), difficulty eating or eating in company (19 %), taste and olfaction (16 %), changes in appetite (9 %) and mobility of the tongue (6 %).

Factor analysis and internal consistency

The five-factor structure as well as the four-factor structure of the SCNS-SF34 could not be replicated in our study sample using confirmatory factor analysis (see supplementary materials). Under the assumption either of correlated factors or of uncorrelated factors, both factor structures had a negative residual variance on item 16 ‘changes in your sexual relationships’. Therefore, we also performed an analysis, in which item 16 was deleted. In that case, both factor models could not be estimated when assuming correlated factors. When assuming correlated factors, both factor models showed inadequate RMSEA scores. Therefore, an exploratory principal component analysis was performed to investigate the factor structure for use in HNC patients. At first, a new five-factor structure was generated (see supplementary materials), replicating the physical and daily living and sexuality domains and almost replicating the psychological needs and health system, information and patient support domain as reported in Au et al. [16]. However, the fifth factor comprised four items (item 17–19 and 24) without clear cohesion. Since three out of these four items had high cross loadings (cross loadings .34 to .51), a second principal component analysis was performed without item 19 (which did not have any cross loadings) and forced into four factors, resulting in the same factor structure as in Au et al. [16]. Although this four-factor structure (Bartlett’s test of sphericity (p < .001) and KMO = .93) did not have a good fit of the model using confirmatory factor analyses, this model is nevertheless proposed to be the best model for use in HNC patients with good internal consistency (Cronbach’s alpha ranging from .79 (sexuality domain) to .95 (psychological)) (Table 3).
Table 3

Floor and ceiling effects of the SCNS-SF34 and suggested factor structure in head and neck cancer patients (n = 201)

ItemFactor loadings1
Lowest score (%)Highest score (%)1234
Physical and daily living 38.8 0
 1. Pain70.92.5.39 .54
 2. Lack of energy/tiredness51.04.5.33.51 .60
 3. Feelings unwell a lot of the time74.61.0.53 .67
 4. Work around the home58.43.0 .76
 5. Not being able to do the things you used to do57.77.5.39.39 .69
Psychological 29.7 0
 6. Anxiety68.02.5 .78 .31
 7. Feeling down or depressed67.71.0.32 .78
 8. Feelings of sadness66.72.0 .81
 9. Fears about the cancer spreading51.58.5 .85
 10. Worry that the results of treatment are beyond your control59.73.5.34 .74
 11. Uncertainty about the future50.05.5.33 .82
 12. Learning to feel in control of your situation58.01.5.35 .68 .41
 13. Keeping a positive look54.23.5.31 .52 .42
 14. Feelings about death and dying65.04.5 .79
 17. Concerns about the worries of those close to you60.52.5.38 .42 .30
Sexuality 69.9 .5
 15. Changes in sexual feelings75.33.0.48 .74
 16. Changes in your sexual relationships77.82.5.36 .84
 31. To be given information about sexual relationships85.4.5 .76
Health system, information and patient support 21.1 0
 18. More choice about which cancer specialists you see67.51.5 .47 .41
 20. Reassurance by medical staff that the way you feel is normal43.52.5 .62 .34.31
 21. Hospital staff attending promptly to your physical needs57.52.0 .73
 22. Hospital staff acknowledging, and showing sensitivity to your feelings and emotional needs55.01.5 .75
 23. Being given written information about the important aspects of your care58.02.0 .75
 24. Being given information (written, diagrams, drawings) about aspects of managing your illness and side effects at home61.54.0 .65 .30
 25. Being given explanations of those tests for which you would like explanations46.22.5 .72 .31
 26. Being adequately informed about the benefits and side effects of treatments before you choose to have them47.24.5 .79
 27. Being informed about your test results as soon as feasible43.311.9 .74 .31
 28. Being informed about cancer which is under control or diminishing (that is, remission)38.310.4 .77 .37
 29. Being informed about things you can do to help yourself to get well50.28.5 .78 .30
 30. Having access to professional counselling (e.g. psychologist, social worker, counsellor, nurse specialist) if you, your family or friends need it66.74.5 .67 .35
 32. Being treated like a person not just another case53.29.5 .79
 33. Being treated in a hospital or clinic that is as physically pleasant as possible44.36.5 .72
 34. Having one member of hospital staff with whom you can talk to about all aspects of your condition, treatment and follow-up47.36.5 .78
 19. More choice about which hospital you attend68.52.0
Eigenvalue16.693.341.671.23
Variance50.5810.115.053.71
Cronbach’s α.95.95.89.79

aLoadings >.3 are presented, and main (i.e. highest) loading is italicized

Floor and ceiling effects of the SCNS-SF34 and suggested factor structure in head and neck cancer patients (n = 201) aLoadings >.3 are presented, and main (i.e. highest) loading is italicized Principal component analysis of the SCNS-HNC showed two underlying constructs, namely HNC-specific functioning and lifestyle (Bartlett’s test of sphericity (p < .001) and KMO = .88) (Table 4). Item 6 was not included in the principal component analysis, since it was not correlated (r < .30) with the other items. Internal consistency of HNC-specific functioning domain was good (Cronbach’s alpha = .89), while below .70 for the two-item lifestyle domain (Cronbach’s alpha = .60).
Table 4

Floor and ceiling effects of the SCNS-HNC and suggested factor structure in head and neck cancer patients (n = 201)

Factor loadingsa
ItemLowest score (%)Highest score (%)12
HNC-specific functioning 21.3 1.0
 1. Problems with chewing and or swallowing47.08.0 .84
 2. Problems with dry mouth and/or sticky mucus36.010.0 .85
 3. Problems with weight (underweight or overweight)47.06.5 .74
 4. To be informed on nutrition57.55.0 .78
 5. Difficulty speaking54.85.0 .77
 7. Problems with hearing71.52.5 .59
 8. Oral hygiene56.64.5 .75
 9. Problems with mobility of neck or shoulders58.87.0 .70
Lifestyle 70.9 .5
 10. Quit smoking81.45.0 .84
 11. Quit drinking78.5.5 .85
 6. Care of your stoma and/or voice prosthesisb 20.030.0
Eigenvalue4.761.39
Variance47.6313.94
Cronbach’s α.89.60

aLoadings >.3 are presented, and main (i.e. highest) loading is italicized

bPercentage of lowest score and percentage of highest score calculated for patients treated with total laryngectomy only

Floor and ceiling effects of the SCNS-HNC and suggested factor structure in head and neck cancer patients (n = 201) aLoadings >.3 are presented, and main (i.e. highest) loading is italicized bPercentage of lowest score and percentage of highest score calculated for patients treated with total laryngectomy only

Construct validity

In total, 27 of the 28 (96 %) hypothesised correlations (seven hypotheses on health system, information and patient support were investigated instead of 11 hypotheses when the five-factor structure would have been replicated) between the SCNS-SF34 and other PROMs were found (Table 1). Sixteen correlations (57 %) also supported the a priori hypothesised magnitude of correlation. Regarding expected differences, three of the ten hypotheses were confirmed (30 %; Table 5). Patients treated with multi-modality treatment reported a higher need on the physical and daily living (p = .015) and psychological domain (p = .009), while no difference was found for health system, information and patient support (p = .070). Patients long after treatment reported less need for health system, information and patient support than patients short after treatment (p = .015). No significant differences were found regarding gender or age.
Table 5

Differences in SCNS-SF34 domain scores between different patient groups

CharacteristicsNumberSCNS domain
Physical and daily living (n = 196)Psychological (n = 195)Sexuality (n = 196)Health system, information and patient support (n = 199)
Median (range) p valueMedian (range) p valueMedian (range) p valueMedian (range) p value
Age
 18–60 years637.5 (0–92.5)0 (0–75.0)13.3 (0–83.3)
 >60 years13810.0 (0–85.0)0 (0–100.0)15.0 (0–91.7)
Gender.11.67.55
 Male13410.0 (0–95.0)10.0 (0–92.5)0 (0–100.0)
 Female6712.5 (0–95.0)10.0 (0–85.0)0 (0–66.7)
Treatment procedure .02 .01 .07
 Single treatment925.0 (0–95.0)5.0 (0–85.0)11.7 (0–85.0)
 Multi modality treatment10910.0 (0–95.0)15.0 (0–92.5)18.3 (0–91.7)
Time since last treatment .02
 0–1 year7819.2 (0–91.7)
 1–2 years6013.3 (0–81.7)
 >2 years637.5 (0–76.7)

Significant differences are italicized

Differences in SCNS-SF34 domain scores between different patient groups Significant differences are italicized Of the SCNS-HNC, 8 of the 9 (89 %) hypothesised correlations were found (Table 1). Six correlations (67 %) also supported the a priori hypothesised magnitude of correlation.

Test–retest reliability

Test–retest reliability of the SCNS-SF34 domains was good (ICC ranged from .74 (sexuality) to .83 (physical and daily living)). Test–retest reliability for HNC-specific functioning was also good (ICC = .83), while it was slightly lower than .70 for the lifestyle domain (ICC = .67).

Presence of floor and/or ceiling effects

On all SCNS-SF34 and SCNS-HNC domains, floor effects were present (Tables 3 and 4). Floor effects (no need for care) ranged from 21.1 % (health system, information and patient support) to 70.9 % (lifestyle). No ceiling effects were present.

Discussion

This study is the first study that investigated the psychometric properties of the Dutch version of the SCNS-SF34 and newly developed SCNS-HNC among HNC patients. Psychometric properties assessed were content validity, factor structure, internal consistency, construct validity and test–retest reliability. Content validity analyses of the SCNS-HNC showed that there were no redundant items, but that some HNC issues may need to be added, namely taste and olfaction, difficulty eating, eating in company and changes in appetite, coughing and breathlessness and mobility of the tongue. For some of these problems, the need for SC was already addressed indirectly, e.g. the problems on difficulty eating, eating in company and changes in appetite were addressed partly by the question on being informed about nutrition, and the problems on mobility of the tongue is addressed by the question on chewing, swallowing and speech. For the other problems/needs (taste and olfaction and coughing and breathlessness), multidisciplinary discussions are needed on the necessity to update the SCNS-HNC. In the present study, we aimed to include only those problems/needs for which SC is available. However, we realize that this aim is not consistent with the tenets of supportive care needs assessment. One of the purposes is to assist in identifying, guiding and designing the range of services that ought to be available to patients [39]. Although an item on taste and olfaction and on coughing and breathlessness may be added, the SCNS-HNC is a comprehensive PROM. Appropriateness of the SCNS-HNC was further supported by the identified two-factor structure, namely HNC-specific functioning, which comprises eight items on needs related to HNC-specific functioning and problems, and a lifestyle domain, which comprises two items related to quitting smoking and drinking. Internal consistency of HNC-specific functioning was good (Cronbach’s alpha = .89), while somewhat low for the lifestyle domain (Cronbach’s alpha = .60), which can be explained by the fact that this domain includes only two items. We acknowledge that a domain with two items is generally recognized as less stable and thereby less reliable and less construct valid than a domain with more items [40]. Regarding the SCNS-SF34, confirmatory factor analyses showed that the five-factor structure of Boyes et al. [9] and the four-factor structure of Au et al. [16] could not be replicated in this study. Nevertheless, exploratory factor analyses showed that the four-factor structure, in which item 19 is deleted, and the domains on health systems and information and patient care and support were combined in one domain (i.e. health system, information and patient support) [16], was the best model for use in HNC patients with good internal consistency (Cronbach’s alpha ranged from .79 to .95). Up till now, this four-factor structure has only been proposed by Au et al. [16]. Other validation studies proposed the (slightly adjusted) five-factor structure of Boyes et al. [9], although these studies also acknowledged some difficulties or inconsistencies when replicating the five-factor structure [11–13, 15, 17, 18]. Okuyama et al. [18], for instance, showed that items 21 and 22 had stronger cross loadings on the health system and information domain, while originally allocated to the patient care and support domain. The same holds for Lehmann et al. [13] who found that item 30 had stronger cross loadings on the psychological domain, while originally allocated to the health care and information domain. In addition, Schofield et al. [11] reported that items 18 and 19 originally allocated to the patient care and support domain did not load (loading <.30) to one of the domains at all, and Doubova et al. [15] excluded item 31 due to high cross loadings. Finally, Brédart et al. [12] and Li et al. [17], the only two studies that performed confirmatory factor analyses, reported that residuals were correlated indicating redundancy among items. Based on these validation studies and our results, as already hypothesised by Li et al. [17], it can be assumed that one universal factor structure for the SCNS-SF34 is unlikely. The factor structure of the SCNS-SF34 may potentially differ regarding, for example, age, gender or cancer diagnosis. To assess construct validity of both the SCNS-SF34 and the SCNS-HNC, our study defined clear a priori hypotheses regarding the (magnitude of) correlation with other PROMs and expected differences between groups of HNC patients. In our study, 96 and 89 % of the hypothesised correlations were found for the SCNS-SF34 and SCNS-HNC, respectively; however, only 57 and 67 % respectively, showed the hypothesised magnitude of correlation. In 11 of the 16 cases, in which the correlation as such was supported but not the magnitude of correlation, a stronger correlation was found than a priori hypothesised based on previous validation studies [9, 11–13, 16, 18] and researchers’ expectations. Regarding discriminative construct validity, patients treated with multi-modality treatment in our study reported higher levels of physical and daily living and psychological needs, and patients long after treatment reported less health system, information and patient support needs. No significant differences in SC needs were found between different gender and age groups. This is in contrast to previous studies which have repeatedly shown such differences [12, 13, 16–18, 35]. A possible explanation for the stronger correlations and absence of differences in SC needs regarding age and gender is that all patients included in our study were at least 3 months after treatment and, in general, had low levels of SC needs, as shown by the high floor effects of 21.1–70.9 %. These high floor effects may have resulted in limited variation in outcomes and consequently in higher correlations and the absence of differences between groups. Another explanation may be that SC needs are different in HNC patients compared to other cancer populations (i.e. breast, prostate and mixed cancer populations) on which our hypotheses were mainly based [9, 11–13, 16, 18, 34, 35]. Our results are in line with the results of Henry et al. which was published after our hypotheses formulation [23], who found relatively high correlations between total SCNS-SF34 score and HADS-D and HADS-A of r = .44 and .53 and no association with gender and age in HNC patients. Finally, test–retest reliability of the SCNS-SF34 and SCNS-HNC was overall shown to be good (ICC ranged from .67 to .83). Only two previous validation studies [12, 15] also assessed test–retest reliability of the SCNS-SF34. They also showed good test–retest reliability, except for the physical and daily living domain in breast cancer patients [12]. A limitation of this study is that we included HNC patients after treatment, limiting generalizability to HNC patients undergoing treatment or other Dutch cancer populations. Therefore, we encourage the validation of the SCNS-SF34 and SCNS-HNC in patients during treatment and other Dutch cancer populations. Another limitation of this study is that although patients were asked to report any additional needs not yet included in the SCNS-HNC, patients did not participate in the developmental stage by interview or focus group. Also, critical review to assess whether all of the items were relevant for the construct being measured and cognitive interviews to determine how the items were perceived or understood by HNC patients were not performed. Main strengths of this study are the development of the SCNS-HNC, which can be used in conjunction with the SCNS-SF34, and the assessment of a wide range of psychometric characteristics including content validity, factor structure, internal consistency, construct validity and test–retest reliability.

Conclusion

In this study, a module was developed for use in conjunction with the SCNS-SF34 that measures SC needs specific for HNC patients (i.e. SCNS-HNC). The SCNS-SF34 and SCNS-HNC are valid and reliable PROMs to evaluate the need for SC among HNC patients. More research on the validation of the SCNS-SF34 and SCNS-HNC in other populations, including HNC patients undergoing treatment is, however, warranted. (DOC 12 kb) (DOC 14 kb)
  36 in total

1.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

2.  Supportive care needs of Mexican adult cancer patients: validation of the Mexican version of the Short-Form Supportive Care Needs Questionnaire (SCNS-SFM).

Authors:  Svetlana V Doubova; Rebeca Aguirre-Hernandez; Marcos Gutiérrez-de la Barrera; Claudia Infante-Castañeda; Ricardo Pérez-Cuevas
Journal:  Support Care Cancer       Date:  2015-02-10       Impact factor: 3.603

3.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

4.  The reliability of a two-item scale: Pearson, Cronbach, or Spearman-Brown?

Authors:  Rob Eisinga; Manfred te Grotenhuis; Ben Pelzer
Journal:  Int J Public Health       Date:  2012-10-23       Impact factor: 3.380

5.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.

Authors:  K Bjordal; E Hammerlid; M Ahlner-Elmqvist; A de Graeff; M Boysen; J F Evensen; A Biörklund; J R de Leeuw; P M Fayers; M Jannert; T Westin; S Kaasa
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

6.  Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer.

Authors:  David P Smith; Rajah Supramaniam; Madeleine T King; Jeanette Ward; Martin Berry; Bruce K Armstrong
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

Review 7.  Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.

Authors:  Lisette van der Molen; Maya A van Rossum; Lori M Burkhead; Ludi E Smeele; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-30       Impact factor: 2.503

Review 8.  Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.

Authors:  Mario Mujica-Mota; Sofia Waissbluth; Sam J Daniel
Journal:  Head Neck       Date:  2012-12-22       Impact factor: 3.147

9.  More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life.

Authors:  Jacqueline A E Langius; Anne M van Dijk; Patricia Doornaert; Hinke M Kruizenga; Johannes A Langendijk; C René Leemans; Peter J M Weijs; Irma M Verdonck-de Leeuw
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

10.  Prevalence and correlates of cancer survivors' supportive care needs 6  months after diagnosis: a population-based cross-sectional study.

Authors:  Allison W Boyes; Afaf Girgis; Catherine D'Este; Alison C Zucca
Journal:  BMC Cancer       Date:  2012-04-18       Impact factor: 4.430

View more
  8 in total

1.  Psychometric testing of the Mandarin version of the 34-item Short-Form Supportive Care Needs Survey in patients with cancer in mainland China.

Authors:  Yuan Han; Ying Zhou; Jing Wang; Qian Zhao; Huiying Qin; Yuying Fan; Yalan Song; Allison Boyes; Shuzhong Cui
Journal:  Support Care Cancer       Date:  2017-05-27       Impact factor: 3.603

2.  Validity and reliability of the Amharic version of supportive care needs survey - short form 34 among cancer patients in Ethiopia.

Authors:  Tsion Afework; Abigiya Wondimagegnehu; Natnael Alemayehu; Eva Johanna Kantelhardt; Adamu Addissie
Journal:  BMC Health Serv Res       Date:  2021-05-21       Impact factor: 2.655

3.  Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial.

Authors:  Anja van der Hout; Cornelia F van Uden-Kraan; Birgit I Witte; Veerle M H Coupé; Femke Jansen; C René Leemans; Pim Cuijpers; Lonneke V van de Poll-Franse; Irma M Verdonck-de Leeuw
Journal:  Trials       Date:  2017-05-22       Impact factor: 2.279

4.  Psychometric properties of the Dutch extended Cancer Survivors' Unmet Needs measure (CaSUN-NL).

Authors:  M C Keeman; C A W Bolman; I Mesters; R A Willems; I M Kanera; L Lechner
Journal:  Eur J Cancer Care (Engl)       Date:  2018-01-22       Impact factor: 2.520

5.  Evaluation of psychometric properties of needs assessment tools in cancer patients: A systematic literature review.

Authors:  Lang Tian; Xiaoyi Cao; Xielin Feng
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

6.  Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.

Authors:  Spela Mirosevic; Belinda Thewes; Carla van Herpen; Johannes Kaanders; Thijs Merkx; Gerry Humphris; Robert J Baatenburg de Jong; Johannes A Langendijk; C René Leemans; Chris H J Terhaard; Irma M Verdonck-de Leeuw; Robert Takes; Judith Prins
Journal:  Head Neck       Date:  2019-06-07       Impact factor: 3.147

7.  Reliability and validity of the mandarin version of the supportive care needs survey short-form (SCNS-SF34) and the head and neck cancer-specific supportive care needs (SCNS-HNC) module.

Authors:  Jianxia Lyu; Li Yin; Ping Cheng; Bin Li; Shanshan Peng; Chunlian Yang; Jing Yang; Haixin Liang; Qinghua Jiang
Journal:  BMC Health Serv Res       Date:  2020-10-16       Impact factor: 2.655

8.  Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity.

Authors:  M Sean Peach; Daniel M Trifiletti; Carolyn Vachani; Karen Arnold-Korzeniowski; Christina Bach; Margaret Hampshire; James M Metz; Christine E Hill-Kayser
Journal:  Patient Relat Outcome Meas       Date:  2018-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.